428 related articles for article (PubMed ID: 10822211)
1. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
Spence JD; Huff M; Barnett PA
Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
[TBL] [Abstract][Full Text] [Related]
2. [Possibilities of using indices of vascular wall function as markers of negative metabolic effects of treatment with thiazide diuretics in patients with essential hypertension].
Semenkin AA
Ter Arkh; 2007; 79(4):31-8. PubMed ID: 17564015
[TBL] [Abstract][Full Text] [Related]
3. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
4. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.
Krum H; Skiba M; Gilbert RE
Diabet Med; 2003 Sep; 20(9):708-12. PubMed ID: 12925048
[TBL] [Abstract][Full Text] [Related]
5. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
6. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
Rosei EA; Rizzoni D;
J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
9. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
Lacourcière Y; Gagné C
J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
Lacourcière Y; Arnott W
J Hum Hypertens; 1994 Apr; 8(4):283-8. PubMed ID: 8021909
[TBL] [Abstract][Full Text] [Related]
11. Step-one antihypertensive therapy: a comparison of a centrally acting agent and a diuretic.
McCarron DA
J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S853-8. PubMed ID: 6084139
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive drugs and blood lipids: the Oslo study.
Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
[TBL] [Abstract][Full Text] [Related]
13. Serum lipoproteins during treatment with antihypertensive drugs.
Weidmann P; de Courten M; Ferrari P; Böhlen L
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
[TBL] [Abstract][Full Text] [Related]
14. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
[TBL] [Abstract][Full Text] [Related]
15. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
Li Y; Liu G; Jiang B; Gao R; Chen L; Su L; Li J
Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176
[TBL] [Abstract][Full Text] [Related]
16. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands.
Hoogerbrugge N; de Groot E; de Heide LH; de Ridder MA; Birkenhägeri JC; Stijnen T; Jansen H
Neth J Med; 2002 Oct; 60(9):354-61. PubMed ID: 12572707
[TBL] [Abstract][Full Text] [Related]
17. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
18. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia of diuretic therapy.
Ames R
Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
